Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Termination of Pregnancy With Mifepristone and Misoprostol Versus Sulprostone

The recruitment status of this study is unknown. The completion date has passed and the status has not been verified in more than two years.
Verified September 2005 by Atrium Medical Center.
Recruitment status was:  Recruiting
Sponsor:
Information provided by:
Atrium Medical Center
ClinicalTrials.gov Identifier:
NCT00206193
First received: September 13, 2005
Last updated: October 29, 2007
Last verified: September 2005

September 13, 2005
October 29, 2007
Not Provided
Not Provided
Not Provided
Not Provided
Complete list of historical versions of study NCT00206193 on ClinicalTrials.gov Archive Site
Not Provided
Not Provided
Not Provided
Not Provided
 
Termination of Pregnancy With Mifepristone and Misoprostol Versus Sulprostone
Not Provided
The purpose of this study is to determine which medical treatment is the most effective to terminate a pregnancy.
Not Provided
Observational
Time Perspective: Prospective
Not Provided
Not Provided
Not Provided
Not Provided
Abortion, Induced
  • Drug: mifepristone
  • Drug: misoprostol
  • Drug: sulprostone
Not Provided
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Unknown status
Not Provided
Not Provided
Not Provided

Inclusion Criteria:

  • Pregnant women by whom a termination of pregnancy is desired.

Exclusion Criteria:

  • Women with liver/kidney disease
  • Women on long-term use of corticosteroids (> 6 months)
  • Cardiovascular problems
  • Therapy-resistant diabetic women
  • Therapy-resistant asthma/bronchitis
  • Thalassemia
  • Ulcerative colitis
  • Peptic ulcer disease
  • Glaucoma
  • Porphyria
  • Allergic reaction to prostaglandin or mifepristone
  • Women with a prior caesarian section or women with contractions at the start of the study
Female
18 Years and older   (Adult, Senior)
Not Provided
Contact information is only displayed when the study is recruiting subjects
Netherlands
 
NCT00206193
TOP-protocol
Not Provided
Not Provided
Not Provided
Not Provided
Atrium Medical Center
Not Provided
Study Director: F Roumen, Dr. Atrium Medisch Centrum, Heerlen
Atrium Medical Center
September 2005

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP